|
Midatech Pharma PLC - Cardiff-based R&D biotechnology company focused on improving the bio-delivery and bio-distribution of medicines - Raises gross proceeds of around $6.0 million through the issue of 10.3 million units at an issue price of $0.58 per unit. One unit either includes one American depository share, one A warrant and one and one-half B warrant, or one pre-funded warrant, one A warrant and one and one-half B warrant. Says that the net proceeds will enable the company to focus on developing MTX110, its clinical asset, and provide it with sufficient working capital until December 2023. Current stock price: 2.10 pence 12-month change: down 86% Copyright 2023 Alliance News Ltd. All Rights Reserved.
|
